Evidence map›Paper›PMID 19542362›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2009

Successful treatment of bacterial infection hinders development of acquired immunity.

Amanda Griffin, Dahabo Baraho-Hassan, Stephen J McSorley

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Lack of homologous protection against Campylobacter jejuni CG8421 in a human challenge model.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2013
    Trial
  2. Article
  3. Dual Immunization with SseB/Flagellin Provides Enhanced Protection againstJournal of immunology (Baltimore, Md. : 1950) · 2017
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Amanda GriffinCenter for Infectious Diseases and Microbiology Translational Research, Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Dahabo Baraho-Hassan
Stephen J McSorley
University of Minnesota Medical Center · US

Funding

CD4 T Cell Response to SalmonellaR01AI055743 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MCSORLEY, STEPHEN J · 2004 to 2013
$3.5M
Typhoid priority antigen identification and vaccine developmentR01AI073672 · NIAID · UNIVERSITY OF MINNESOTA · PI MCSORLEY, STEPHEN J · 2008 to 2011
$1.6M
NIAID NIH HHS AI055743NIAID NIH HHS AI073672NIAID NIH HHS R01 AI055743NIAID NIH HHS R01 AI073672
6 · The paper itself

Abstract

Antibiotics are routinely used to control bacterial infection, but the acquisition of acquired immunity following successful treatment has rarely been examined. We developed a model that allows visualization of acquired immunity during and following antibiotic treatment of typhoid. Pathogen-specific humoral and cellular immune responses were activated rapidly in antibiotic-treated mice, but were not sustained after successful antibiotic treatment and did not confer protection to secondary infection. In marked contrast, pathogen-specific Th1 and Ab responses matured over several weeks following immunization with a live vaccine strain. The deficiency in protective immunity following antibiotic treatment could be overcome by administering flagellin during antibiotic therapy. Thus, development of protective immunity is hindered by rapid therapeutic elimination of bacteria, but can be overcome by providing additional inflammatory and/or antigenic stimuli.

Indexed as

AnimalsAnti-Bacterial AgentsAntibody FormationAntigensBacterial InfectionsFlagellinImmunity, CellularInflammationMiceMice, TransgenicTh1 CellsTreatment OutcomeVaccines, AttenuatedAnti-Bacterial AgentsAntigensFlagellinVaccines, Attenuated

Identifiers

PMID19542362
PMCPMC2706945
OpenAlexW1501630319

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.